Cargando…
A case of vildagliptin-induced interstitial pneumonia
A 65-year-old Japanese male with type 2 diabetes mellitus was admitted to our hospital with a productive cough and worsening dyspnea. He had started receiving vildagliptin, which is one of the dipeptideylpeptidase-4 (DPP-4) inhibitors, several days before the appearance of his symptoms. Laboratory f...
Autores principales: | Kuse, Naoyuki, Abe, Shinji, Kuribayashi, Hidehiko, Inomata, Minoru, Saito, Hitoshi, Fukuda, Yuh, Gemma, Akihiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4840426/ https://www.ncbi.nlm.nih.gov/pubmed/27144110 http://dx.doi.org/10.1016/j.rmcr.2016.03.005 |
Ejemplares similares
-
Marked improvement in leptomeningeal carcinomatosis and spinal cord metastases following alectinib treatment of crizotinib-resistant, ALK-positive lung adenocarcinoma
por: Kuribayashi, Hidehiko, et al.
Publicado: (2015) -
Anti-MDA5 Antibody-positive Clinically Amyopathic Dermatomyositis Complicated by Unilateral Right-sided Interstitial Lung Disease
por: Kori, Mayuko, et al.
Publicado: (2020) -
Prognostic Factors in the Acute Exacerbation of Idiopathic Pulmonary Fibrosis: A Retrospective Single-center Study
por: Atsumi, Kenichiro, et al.
Publicado: (2017) -
Distinct Profiles of CD163-Positive Macrophages in Idiopathic Interstitial Pneumonias
por: Yamashita, Masahiro, et al.
Publicado: (2018) -
Anti-MDA5 antibody-positive rapidly progressive interstitial pneumonia without cutaneous manifestations
por: Aoyama, Junichi, et al.
Publicado: (2019)